FN2 Earnings Intelligence
Cardinal Health, Inc. financials
Cardinal Health, Inc. (CAH) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 | 6/30/2026 | 12/31/2026 est. | 6/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $4,717 | $4,043 | $5,133 | $3,874 | $4,856 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $181,364 | $205,012 | $226,827 | $222,578 | $254,248 | $275,628.5 | $265,748 |
| % Growth | 11.6% | 13.0% | 10.6% | -1.9% | 14.2% | - | 4.5% |
| Gross Profit | $6,545 | $6,889 | $7,414 | $8,168 | $9,774 | - | - |
| % Margin | 3.6% | 3.4% | 3.3% | 3.7% | 3.8% | - | - |
| EBITDA | $96 | $1,419 | $1,953 | $3,065 | $3,569 | - | - |
| % Margin | 0.1% | 0.7% | 0.9% | 1.4% | 1.4% | - | - |
| Net Income | -$933 | $261 | $852 | $1,561 | $1,714 | - | - |
| % Margin | -0.5% | 0.1% | 0.4% | 0.7% | 0.7% | - | - |
| Diluted EPS | -$3.35 | $1.00 | $3.45 | $6.45 | $7.23 | $12.08 | $12.54 |
| % Growth | -261.1% | 129.9% | 245.0% | 87.0% | 12.1% | - | 73.5% |
| Operating Cash Flow | $3,122 | $2,839 | $3,762 | $2,397 | $5,174 | - | - |
| CapEx | $387 | $481 | $511 | $547 | $649 | - | - |
| Free Cash Flow | $2,735 | $2,358 | $3,251 | $1,850 | $4,525 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 | 6/30/2026 | 12/31/2026 est. | 6/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $181,364 | $205,012 | $226,827 | $222,578 | $254,248 | $275,628.5 | $265,748 |
| Gross Profit | $6,545 | $6,889 | $7,414 | $8,168 | $9,774 | - | - |
| EBITDA | $96 | $1,419 | $1,953 | $3,065 | $3,569 | - | - |
| Net Income | -$933 | $261 | $852 | $1,561 | $1,714 | - | - |
| Diluted EPS | -$3.35 | $1.00 | $3.45 | $6.45 | $7.23 | $12.08 | $12.54 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $4,717 | $4,043 | $5,133 | $3,874 | $4,856 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $3,122 | $2,839 | $3,762 | $2,397 | $5,174 |
| Capital Expenditure | $387 | $481 | $511 | $547 | $649 |
| Free Cash Flow | $2,735 | $2,358 | $3,251 | $1,850 | $4,525 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | 11.6% | 13.0% | 10.6% | -1.9% | 14.2% |
| Gross Margin | 3.6% | 3.4% | 3.3% | 3.7% | 3.8% |
| EBITDA Margin | 0.1% | 0.7% | 0.9% | 1.4% | 1.4% |
| Net Margin | -0.5% | 0.1% | 0.4% | 0.7% | 0.7% |
| FCF Margin | 1.5% | 1.2% | 1.4% | 0.8% | 1.8% |
| Diluted EPS Growth | -261.1% | 129.9% | 245.0% | 87.0% | 12.1% |